NECTIN4: A Novel Therapeutic Target for Melanoma

Malignant melanoma is the most common lethal skin cancer and causes death in a short time when metastasized. Although BRAF inhibitors (BRAFi) have greatly improved the prognosis of BRAF-mutated melanoma, drug resistance is a major concern even when they are combined with MEK inhibitors. Alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yuka, Murata, Maho, Shen, Che-Hung, Furue, Masutaka, Ito, Takamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835875/
https://www.ncbi.nlm.nih.gov/pubmed/33478111
http://dx.doi.org/10.3390/ijms22020976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835875/
https://www.ncbi.nlm.nih.gov/pubmed/33478111
http://dx.doi.org/10.3390/ijms22020976

Ejemplares similares